Vassilaros S - Search Results

1

Pilot Study: Immune Checkpoints Polymorphisms in Greek Primary Breast Cancer Patients.

Kuol N, Yan X, Barriga V, Karakkat J, Vassilaros S, Fyssas I, Tsimpanis A, Fraser S, Nurgali K, Apostolopoulos V. Kuol N, et al. Among authors: vassilaros s. Biomedicines. 2022 Jul 29;10(8):1827. doi: 10.3390/biomedicines10081827. Biomedicines. 2022. PMID: 36009373 Free PMC article.

2

Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1.

Vassilaros S, Tsibanis A, Tsikkinis A, Pietersz GA, McKenzie IF, Apostolopoulos V. Vassilaros S, et al. Immunotherapy. 2013 Nov;5(11):1177-82. doi: 10.2217/imt.13.126. Immunotherapy. 2013. PMID: 24188672 Clinical Trial.

3

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].

Apostolopoulos V, Pietersz GA, Tsibanis A, Tsikkinis A, Drakaki H, Loveland BE, Piddlesden SJ, Plebanski M, Pouniotis DS, Alexis MN, McKenzie IF, Vassilaros S. Apostolopoulos V, et al. Among authors: vassilaros s. Breast Cancer Res. 2006;8(3):R27. doi: 10.1186/bcr1505. Epub 2006 Jun 15. Breast Cancer Res. 2006. PMID: 16776849 Free PMC article. Clinical Trial.

4

Dendritic cell immunotherapy: clinical outcomes.

Apostolopoulos V, Pietersz GA, Tsibanis A, Tsikkinis A, Stojanovska L, McKenzie IF, Vassilaros S. Apostolopoulos V, et al. Among authors: vassilaros s. Clin Transl Immunology. 2014 Jul 18;3(7):e21. doi: 10.1038/cti.2014.14. eCollection 2014 Jul. Clin Transl Immunology. 2014. PMID: 25505969 Free PMC article. Review.

5

Pregnancy and offspring after the appearance of breast cancer.

Malamos NA, Stathopoulos GP, Keramopoulos A, Papadiamantis J, Vassilaros S. Malamos NA, et al. Among authors: vassilaros s. Oncology. 1996 Nov-Dec;53(6):471-5. doi: 10.1159/000227622. Oncology. 1996. PMID: 8960142

6

Microsatellite instability and loss of heterozygosity in primary breast tumours.

Sourvinos G, Kiaris H, Tsikkinis A, Vassilaros S, Spandidos DA. Sourvinos G, et al. Among authors: vassilaros s. Tumour Biol. 1997;18(3):157-66. doi: 10.1159/000218026. Tumour Biol. 1997. PMID: 9143412

7

Estrogen receptors β1 and β2 are associated with distinct responses of estrogen receptor α-positive breast carcinoma to adjuvant endocrine therapy.

Dhimolea E, Tiniakos DG, Chantzi ΝΙ, Goutas N, Vassilaros SD, Mitsiou DJ, Alexis ΜN. Dhimolea E, et al. Among authors: vassilaros sd. Cancer Lett. 2015 Mar 1;358(1):37-42. doi: 10.1016/j.canlet.2014.12.022. Epub 2014 Dec 15. Cancer Lett. 2015. PMID: 25524554

8

Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.

Chantzi NI, Tiniakos DG, Palaiologou M, Goutas N, Filippidis T, Vassilaros SD, Dhimolea E, Mitsiou DJ, Alexis MN. Chantzi NI, et al. Among authors: vassilaros sd. J Cancer Res Clin Oncol. 2013 Sep;139(9):1489-98. doi: 10.1007/s00432-013-1467-4. Epub 2013 Jul 2. J Cancer Res Clin Oncol. 2013. PMID: 23817696

9

Expression of ras Rb1 and p53 proteins in human breast cancer.

Spandidos DA, Karaiossifidi H, Malliri A, Linardopoulos S, Vassilaros S, Tsikkinis A, Field JK. Spandidos DA, et al. Among authors: vassilaros s. Anticancer Res. 1992 Jan-Feb;12(1):81-9. Anticancer Res. 1992. PMID: 1567185

10

Elevated expression of AP-1 activity in human breast tumors as compared to normal adjacent tissue.

Linardopoulos S, Malliri A, Pintzas A, Vassilaros S, Tsikkinis A, Spandidos DA. Linardopoulos S, et al. Among authors: vassilaros s. Anticancer Res. 1990 Nov-Dec;10(6):1711-3. Anticancer Res. 1990. PMID: 2285246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page